The FDA approved the first oral GLP1 medication for chronic weight management in adults with obesity or overweight and related health risks on December 22, 2025, marking it as the first oral treatment of its kind in the US
(PubMed) Yang SJ, Hwang SY, Choi HY, et al
Michael Murray, we have developed products that enhance overall well-being and demonstrate our dedication to addressing our customers' needs. A growing market According to a recent survey by KFF and reported by CNN, about 6% of American adults, or more than 15 million people, are currently being prescribed GLP-1 drugs like Ozempic or Mounjaro
Reddy's, available in 2 mg and 4 mg injection pens with an 8 mg pen to follow shortly
Botox, of course, is not a filler, and only lasts 3-4 months
One of Englands youngest players, 19-year-old Bukayo Saka, took the decisive penalty and has reportedly received the largest amount of abuse